Antenatal Care (ANC) in India and UAE | Complete Patient Guide

• All pregnant women seeking structured, supervised prenatal care from 6–12 weeks gestation through delivery planning

• Women with confirmed singleton, twin, or higher-order multiple pregnancies requiring specialized surveillance

• Patients with pre-existing maternal medical conditions: Type 1 or Type 2 diabetes mellitus, chronic hypertension, autoimmune disorders (SLE, antiphospholipid syndrome), thyroid dysfunction, cardiac disease (including congenital heart disease), renal disease, or epilepsy

• Women with prior obstetric history of pre-eclampsia, preterm birth (<37 weeks), recurrent pregnancy loss (≥2 consecutive miscarriages), fetal growth restriction, or stillbirth

• Advanced maternal age (AMA): women aged 35 years or older, who carry elevated risks of aneuploidy and placental dysfunction

• Women with identified genetic carrier status or family history of chromosomal/single-gene disorders requiring fetal genetic counseling and diagnostic procedures (chorionic villus sampling/CVS or amniocentesis)

• Patients requiring first-trimester Down syndrome screening, NIPT (Non-Invasive Prenatal Testing), or detailed fetal anomaly scanning

Required Diagnostics at Enrollment:

• Complete blood count (CBC), blood group and Rh typing, indirect Coombs test

• Random blood glucose or HbA1c; oral glucose tolerance test (OGTT) at 24–28 weeks

• TORCH serology panel (Toxoplasma, Rubella, CMV, HSV)

• HIV, HBsAg, VDRL/RPR, and Hepatitis C screening

• Urine routine microscopy and mid-stream culture

• Thyroid-stimulating hormone (TSH)

• First-trimester combined screen (NT ultrasound + PAPP-A + free β-hCG) between 11–13+6 weeks

• Anatomy/anomaly scan at 18–22 weeks; growth and Doppler scans from 28 weeks onward

• Fetal echocardiography (if indicated) at 20–24 weeks

• Cervical length transvaginal ultrasound in high-risk cases at 16–24 weeks

Contraindications / Special Considerations:

• ANC is universally indicated for all pregnancies; there are no absolute contraindications to antenatal surveillance itself

• Invasive procedures (CVS, amniocentesis) carry a procedure-related miscarriage risk of 0.5–1% and require informed consent

• Long-distance travel for ANC enrollment is generally not recommended beyond 28–32 weeks gestation without specialist clearance; patients planning international ANC should enroll before 20 weeks

• Airlines typically require a medical certificate for travel after 28 weeks (singles) or 24 weeks (multiples)

Antenatal Care is delivered across a spectrum of intensity and complexity, stratified by maternal risk profile:

1. Standard Low-Risk ANC Protocol:

Following WHO 2016 guidelines, low-risk singleton pregnancies receive a minimum of 8 structured antenatal contacts. Each visit includes standardized maternal assessments (weight, blood pressure, fundal height measurement, fetal heart auscultation via Doppler), urinalysis for proteinuria and glycosuria, and trimester-specific laboratory investigations. Nutritional supplementation protocols include folic acid (400–5,000 mcg/day based on risk), iron (ferrous sulfate or ferrous fumarate), calcium supplementation (1.5–2g/day in low-calcium diet populations to reduce pre-eclampsia risk), and Vitamin D3. Low-dose aspirin (75–150 mg/day from 12–16 weeks) is prescribed for women identified as high-risk for pre-eclampsia based on first-trimester combined screening algorithms (Fetal Medicine Foundation algorithm).

2. High-Risk & Maternal-Fetal Medicine (MFM) Specialist ANC:

Women with complex medical or obstetric histories are co-managed by MFM subspecialists. This tier incorporates uterine artery Doppler pulsatility index (PI) measurement for placental insufficiency prediction, serial middle cerebral artery (MCA) Doppler for fetal anemia surveillance (particularly in Rh-sensitized pregnancies requiring intrauterine transfusion/IUT), biophysical profile (BPP) scoring, and computerized cardiotocography (cCTG). Pharmacological interventions include low-molecular-weight heparin (LMWH — enoxaparin, dalteparin) for antiphospholipid syndrome and thrombophilia-associated pregnancy loss, progesterone supplementation (vaginal micronized progesterone 200–400 mg/day or 17-alpha-hydroxyprogesterone caproate) for cervical incompetence and preterm prevention, and magnesium sulfate neuroprotection protocols for imminent preterm delivery before 32 weeks.

3. Fetal Diagnostic & Interventional Procedures:

• Non-Invasive Prenatal Testing (NIPT/cfDNA): Cell-free fetal DNA analysis from 10 weeks gestation for chromosomal aneuploidies (trisomies 13, 18, 21), sex chromosome abnormalities, and select microdeletion syndromes — with sensitivity >99% for trisomy 21

• Chorionic Villus Sampling (CVS): Transcervical or transabdominal placental biopsy at 11–13 weeks for definitive karyotyping, microarray chromosomal analysis (CMA), or single-gene disorder diagnosis

• Amniocentesis: Transabdominal amniotic fluid sampling at 15–20 weeks for karyotyping, microarray, biochemical analysis, or fetal lung maturity assessment

• Fetal Echocardiography: High-resolution cardiac anatomy and function assessment at 20–24 weeks using pulsed-wave, color-flow, and tissue Doppler imaging

• Intrauterine Transfusion (IUT): Ultrasound-guided umbilical vein transfusion for severe fetal anemia (MCA PSV >1.5 MoM)

• Fetoscopic Laser Photocoagulation: Minimally invasive endoscopic surgery for twin-to-twin transfusion syndrome (TTTS) in monochorionic twin pregnancies — targeting placental anastomotic vessels using Nd:YAG laser under continuous fetoscopic visualization

4. Integrated Digital & Telehealth ANC:

Leading centers in India and the UAE offer app-based remote monitoring platforms for blood pressure and fetal movement tracking, teleconsultation slots with MFM specialists between clinic visits, and AI-assisted CTG interpretation systems — enabling international patients to maintain continuity of care with their GAF Healthcare clinical team even during brief returns to their home country.

Step 1 — Pre-Enrollment & Remote Consultation (Before Travel, 6–10 Weeks Gestation):

GAF Healthcare coordinates a telemedicine pre-assessment with a shortlisted MFM specialist. The patient submits existing obstetric records, prior pregnancy history, and relevant medical documentation. The clinical team determines risk stratification, designs a personalized ANC schedule, and advises on optimal gestational age for travel and enrollment.

Step 2 — First Trimester Enrollment Visit (10–13 Weeks Gestation):

Comprehensive booking visit: full medical history, physical examination, baseline blood panel (CBC, blood group, TORCH, HIV, HBsAg, TSH, glucose, urine culture), blood pressure profiling, and nuchal translucency (NT) ultrasound with combined first-trimester screening. NIPT blood draw if opted. Nutritional and supplementation plan initiated. Risk score calculated using validated tools (Fetal Medicine Foundation pre-eclampsia algorithm, NICE clinical guideline risk stratification). Low-dose aspirin initiated if indicated.

Step 3 — Second Trimester Visits (14–27 Weeks Gestation):

Anomaly scan at 18–22 weeks (detailed structural survey of fetal brain, spine, cardiac four-chamber view, abdominal organs, limbs, face, and amniotic fluid index). Fetal echocardiography if indicated. OGTT at 24–28 weeks for GDM screening. Cervical length measurement in preterm-risk patients. Rh-immunoglobulin (anti-D) prophylaxis at 28 weeks for Rh-negative mothers. Review of NIPT results and genetic counseling if required. Amniocentesis or CVS performed with full informed consent if diagnostic clarification needed.

Step 4 — Third Trimester Surveillance (28–36 Weeks Gestation):

Serial growth ultrasounds every 2–4 weeks. Umbilical artery and MCA Doppler assessments. Computerized CTG (cardiotocography) monitoring from 32 weeks. GBS rectovaginal swab at 35–37 weeks. Birth plan discussion including mode of delivery, place of delivery, and neonatal unit availability. Corticosteroid administration (betamethasone 12 mg IM x 2 doses, 24 hours apart) for fetal lung maturity if preterm delivery anticipated before 34 weeks.

Step 5 — Delivery Planning & Handover:

At 36–38 weeks, the MFM team prepares a comprehensive antenatal summary and transition plan. For patients planning to deliver in their home country, a fit-to-fly assessment, detailed discharge summary, and encrypted digital medical record package are provided. For patients delivering locally, the team coordinates with the hospital's obstetrics unit for intrapartum care continuity. Postpartum postnatal care visit scheduled at 6 weeks.

Recovery Milestones:

• Uncomplicated ANC with delivery: postnatal review at 6 weeks; international travel typically feasible 6–8 weeks postpartum (4–6 weeks post-cesarean with clearance)

• High-risk pregnancies: postnatal follow-up per subspecialist recommendation before intercontinental travel